First Time Loading...

Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 59.53 USD -0.65% Market Closed
Updated: May 20, 2024

EV/EBIT
Enterprise Value to EBIT

-12.5
Current
-13.5
Median
4.4
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-12.5
=
Enterprise Value
6.2B
/
EBIT
-498m
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-12.9
2-Years Forward
EV/EBIT
-13.5
3-Years Forward
EV/EBIT
-24.3

See Also

Discover More